US 10689347
Substituted heterocyclyl derivatives as CDK inhibitors
granted A61KA61K31/415A61K31/4155
Quick answer
US patent 10689347 (Substituted heterocyclyl derivatives as CDK inhibitors) held by Aurigene Discovery Technologies Limited expires Mon Jun 18 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Aurigene Discovery Technologies Limited
- Grant date
- Tue Jun 23 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 18 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 30
- CPC classes
- A61K, A61K31/415, A61K31/4155, A61K31/416, A61K31/4439